| Financial Year |
March 31 2023 |
| Monetary Funds |
920,415,008.99 |
| Held-for-trading Financial Assets |
233,067,562.68 |
| Notes Receivable |
44,706,102.56 |
| Accounts Receivable |
168,247,143.10 |
| Advances to Suppliers |
18,384,515.45 |
| Other Receivables |
23,013,330.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
50,605,440.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,624,274.32 |
| Total Current Assets |
1,464,063,377.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
77,614,161.39 |
| Investment Properties |
-- |
| Fixed Assetes |
200,606,065.24 |
| Under-construction Projects |
295,688,591.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
137,570,307.19 |
| R&D expenses |
52,976,205.84 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,604,513.46 |
| Deferred Income Tax Assets |
4,886,541.46 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
793,662,721.90 |
| Total Assets |
2,257,726,099.79 |
| Short-Term Loans |
20,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
5,373,862.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,100,808.29 |
| Taxes Payable |
17,078,827.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,496,237.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,600,068.37 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
93,923,519.13 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
89,194.16 |
| Other Non-Current Liabilities |
28,218,783.21 |
| Sub-Total of Non-Current Liabilities |
69,759,246.60 |
| Total Liabilities |
163,682,765.73 |
| Paid-In Capital(Or Share Stock) |
523,584,000.00 |
| Capital Surplus |
128,194,388.22 |
| Surplus Reserve |
235,115,138.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,163,098,818.34 |
| Minority Stockholder's Interest |
44,030,417.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,050,012,917.00 |
| Owner's Equity（Stockholder's Equity） |
2,094,043,334.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,257,726,099.79 |
